131 related articles for article (PubMed ID: 19816172)
21. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
[TBL] [Abstract][Full Text] [Related]
22. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S
Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
25. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
26. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
27. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous MALT-type lymphoma and early adenocarcinoma of the stomach associated with Helicobacter pylori gastritis.
Müller S; Seifert E; Stolte M
Z Gastroenterol; 1999 Feb; 37(2):153-7. PubMed ID: 10190248
[TBL] [Abstract][Full Text] [Related]
29. Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis?
Cammarota G; Larocca LM; D'Ugo D; Persiani R; Cianci R; Nocente R; Picciocchi A; Gasbarrini G
Hepatogastroenterology; 2001; 48(37):104-6. PubMed ID: 11268940
[TBL] [Abstract][Full Text] [Related]
30. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
31. Imatinib in gastrointestinal stromal tumors.
Bakshi CA; Jain RA; Sastry PS; Sainani AR; Advani SH
J Assoc Physicians India; 2004 May; 52():403-9. PubMed ID: 15656032
[TBL] [Abstract][Full Text] [Related]
32. [Gastric lymphoma].
Ruskoné-Fourmestraux A
Rev Prat; 1997 Apr; 47(8):848-54. PubMed ID: 9183962
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic management of early gastric cancer.
Reshamwala PA; Darwin PE
Curr Opin Gastroenterol; 2006 Sep; 22(5):541-5. PubMed ID: 16891887
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumors: pathogenesis and current treatment.
Arru JM; Richardson JD
J Ky Med Assoc; 2005 May; 103(5):211-5. PubMed ID: 15918651
[TBL] [Abstract][Full Text] [Related]
35. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents.
Ono S; Fujishiro M; Niimi K; Goto O; Kodashima S; Yamamichi N; Omata M
Dig Liver Dis; 2009 Oct; 41(10):725-8. PubMed ID: 19230799
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of treatment and prognosis in 132 patients with gastric gastrointestinal stromal tumors].
Wang G; Zhang RP; Zhao JZ; Wang XJ; Ke B
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):492-6. PubMed ID: 20658361
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and therapy of primary stomach lymphoma. Consensus of the Surgical Working Group for Oncology, the Working Group for Medical Oncology and the Working Group for Radiologic Oncology].
Junginger T; Hossfeld DK; Müller RP
Dtsch Med Wochenschr; 1997 Dec; 122(50):1569-72. PubMed ID: 9445780
[No Abstract] [Full Text] [Related]
38. [Primary gastric lymphoma of the MALT type. The current knowledge on its etiology, therapy and prognosis].
Fischbach W; Wilms K
Strahlenther Onkol; 1995 Oct; 171(10):549-53. PubMed ID: 8571173
[TBL] [Abstract][Full Text] [Related]
39. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
Shen L; Jin ML
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
[TBL] [Abstract][Full Text] [Related]
40. Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.
Artinyan A; Kim J; Soriano P; Chow W; Bhatia S; Ellenhorn JD
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2194-201. PubMed ID: 18708414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
